Ali Ahmed O A, Prins Martin H
General Directorate of Infectious Disease Control, Ministry of Health, Riyadh, Saudi Arabia.
Department of Epidemiology, Maastricht University Medical Centre, Maastricht, the Netherlands.
East Mediterr Health J. 2017 Aug 20;23(6):408-414. doi: 10.26719/2017.23.6.408.
Defaulting on tuberculosis (TB) treatment remains a challenge to controlling TB. This case-control study aimed to identify determinants of treatment default among TB patients attending treatment clinics in Khartoum State from May to July 2011. Cases were TB patients who defaulted on treatment and controls were those who completed treatment. Of the 2727 TB patients attending the clinics, 328 (14%) had defaulted. Of these, 185 had resumed treatment before data collection and 143 had not and were eligible as cases. Of the 143, 27 could not be traced and 11 declined to participate. Thus, 105 cases and 210 controls were included and interviewed. The variables significantly associated with treatment default were: rural residence (OR: 2.68; 95% CI: 1.51-4.73), not being on a DOTS programme (OR: 2.53; 95% CI: 1.49-4.30), having side-effects from treatment (OR: 1.94; 95% CI: 1.14-3.29), and having a history of TB (relapse, multidrug-resistant TB or treatment failure) (OR: 5.11; 95% CI: 2.69-9.69). Attention should be paid to these groups at risk of defaulting to encourage treatment adherence and continuation.
结核病治疗中断仍是控制结核病的一项挑战。本病例对照研究旨在确定2011年5月至7月在喀土穆州治疗诊所就诊的结核病患者中治疗中断的决定因素。病例为治疗中断的结核病患者,对照为完成治疗的患者。在前往诊所就诊的2727名结核病患者中,328名(14%)出现了治疗中断。其中,185名在数据收集前已恢复治疗,143名未恢复且符合病例条件。在这143名患者中,27名无法追踪,11名拒绝参与。因此,纳入并访谈了105例病例和210名对照。与治疗中断显著相关的变量有:农村居民(比值比:2.68;95%置信区间:1.51 - 4.73)、未参加直接督导下的短程化疗(DOTS)项目(比值比:2.53;95%置信区间:1.49 - 4.30)、有治疗副作用(比值比:1.94;95%置信区间:1.14 - 3.29)以及有结核病病史(复发、耐多药结核病或治疗失败)(比值比:5.11;95%置信区间:2.69 - 9.69)。应关注这些有治疗中断风险的群体,以鼓励坚持治疗并持续治疗。